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Abstract
Background: Female genital mutilation (FGM) is commonly practiced mainly in a belt reaching
from East to West Africa north of the equator. The practice is known across socio-economic
classes and among different ethnic, religious, and cultural groups. Few studies have been
appropriately designed to measure the health effects of FGM. However, the outcome of FGM on
intersex individuals has never been discussed before.
Case presentation: The patient first presented as a female with delayed puberty. Hormonal
analysis revealed a normal serum prolactin level of 215 Mu/L, a low FSH of 0.5 Mu/L, and a low LH
of 1.1 Mu/L. Type IV FGM (Pharaonic circumcision) had been performed during childhood.
Chromosomal analysis showed a 46, XY karyotype and ultrasonography verified a soft tissue
structure in the position of the prostate.
Conclusion: FGM pose a threat to the diagnosis and management of children with abnormal
genital development in the Sudan and similar societies.
Background
Female circumcision, or female genital mutilation (FGM),
is defined by the World Health Organization as "all pro-
cedures involving partial or total removal of the external
female genitalia or other injury to the female genital
organs, whether for cultural or other non-therapeutic rea-
sons" [1]. Girls are commonly circumcised between the
ages of 4 and 10 years, but in some communities the pro-
cedure may be performed on infants, or it may be post-
poned until just before marriage or even after the birth of
the first child [2]. Female circumcision is practiced in 28
countries in the sub-Saharan and northeastern regions of
Africa [3]. It affects over 132 million girls and women
worldwide, with an additional two million girls at risk of
some form of the practice each year [4]. The practice is
known across socioeconomic classes and among different
ethnic and cultural groups, including Christians, Mus-
lims, Jews, and followers of indigenous African religions
[5].
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sified FGM into four main types: Type I, which is known
in Sudan as "sunna", represents the excision of a part or
the entire clitoris. Type II involves clitoridectomy and
excision of parts of the labia minora. Types III and IV are
called infibulations. Type III represents clitoridectomy,
removal of the labia minora, excision of the labia majora,
and stitching of the anterior two thirds of the labia majora
leaving a small posterior opening. Type IV, Pharaonic cir-
cumcision or total infibulation, refers to the complete
removal of the clitoris and labia minora, excision of the
labia majora, and stitching of the whole raw area leaving
a very small posterior opening for the passage of urine and
menstrual blood [2]. According to the National Demo-
graphic and Health Survey (1989/1990) infibulation is
the predominant type of FGM practiced in Sudan
throughout most of the northern, north-eastern and
north-western regions, with a small overall decline in the
1980s, when a shift occurred from infibulation to clitori-
dectomy [6]. Although the practice was originally out-
lawed in Sudan in 1946 and again in 1974, the United
Nations has pointed out that "Sudan has the highest prev-
alence of female genital mutilation in the world" [7,8].
More than 90% of women in Sudan have undergone
FGM. Tradition and social pressure are the main motives
for performing FGM [10].
FGM is usually performed by a layperson with limited
anatomical knowledge and medical training; it is an inva-
sive and painful surgical procedure that is usually per-
formed without anesthesia, or with local anesthesia, often
resulting in serious psychological and medical complica-
tions for the young girls. Immediate complications
include hypovolaemic shock, hemorrhage, infection, teta-
nus, and damage to the urethra or anus. Late complica-
tions include keloid formation, dermoid cyst,
dyspareunia, pelvic infection, and pregnancy complica-
tions [11]. Furthermore, there is an association between
the anatomical extent of FGM and primary infertility [12].
When FGM is performed on children with abnormal gen-
italia (e.g. ambiguous genitalia, micropenis, and hypospa-
dia), the consequences are likely to be even more
catastrophic, resulting in irreversible medical problems.
Case presentation
Case history
A 21-year-old Sudanese patient, socially assigned as
female, was referred from her gynaecologist as a case of
delayed puberty for chromosomal analysis. The patient
was born in one of the small towns in the centre of Sudan.
A midwife decided the sex as female at the time of birth.
Thus, she was given a female name and raised as a female.
The patient thinks of her self as a female and was very shy
to tell if she was attracted to males or females, which
could be due to her cultural background. On examination
The patient dressed as a femaleFigure 1
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facial hair (Figure 1), she was rather muscular, had broad
shoulders with wide distance between the nipples, and
absence of breasts or breast buds (Figure 2). The patient
was about 175 cm tall and had female voice. Examination
of the external genitalia showed Type IV FGM (Figure 3).
There was neither pubic hair nor increased pigmentation
in the genital area. Per rectum examination raised the sus-
picion of a prostate. Hormonal analysis revealed a serum
prolactin level of 215 Mu/L, FSH of 0.5 Mu/L, and LH of
1.1 Mu/L (normal values: serum prolactin: 60–370 Mu/L,
serum FSH: 1–8 Mu/L, serum LH: 2–10 Mu/L).
Cytogenetic analysis
A peripheral blood sample of the patient was subjected to
short-term culture in RPMI 1640 medium for three days,
treated with Colcemide and hypotonic solution, and then
fixed with methanol and acetic acid according to standard
procedures. The harvested cells were dropped on clean
slides and stained with Wright's stain, for chromosome
banding [13]. The clonality criteria and the karyotypic
descriptions were according to the ISCN (1995) recom-
mendations [14].
Cytogenetic analysis showed a normal male karyotype,
46, XY [27]. Ultrasound examination confirmed the pres-
ence of a 15 × 15 mm diameter soft tissue mass in the
position of the male prostate (Figure 4).
Conclusion
Although the two terms, sex and gender, are not identical,
they are often used interchangeably in the language. Sex is
defined based on gonads, or potential gonads, either phe-
notypically or genotypically. The sex of a child is usually
assigned at birth based on the external genital appearance,
while gender refers to the socially constructed roles and
responsibilities assigned to women and men in a given
culture. Thus, gender is distinct from sex, which is biolog-
ically determined. The gender of the patient described
here was female. The patient's sex, on the other hand, was
clearly ambiguous and the precise diagnosis remains
unclear. According to her history, she had been classified
as a girl at birth, but there were no records available of the
configuration of her external genitalia. The patient under-
went type IV FGM (Pharaonic circumcision) at an early
age. This might have limited the possibility of clinical
assessment, although the configuration of the external
genitalia is not always essential for a correct diagnosis, as
over-masculinized female pseudohermaphrodites can be
similar to under-masculinized male pseudohermaphro-
dites. The male chromosome complement suggests that
the patient suffered from a type of male pseudohermaph-
roditism, such as complete or incomplete androgen insen-
sitivity syndrome. The low LH and FSH values could
support this diagnosis, but the absence of breast develop-
ment and the complete absence of pubic hair do not sup-
port it. The low LH and FSH could also suggest a delayed
puberty condition. However it cannot be excluded that
ectopic testicular tissue in or close to the labia majora was
excised during the FGM process, thus explaining the
absence of puberty signs. Moreover, one cannot exclude
non-intersex abnormalities of the male genital organs
The patient's external genitaliaFigure 3
The patient's external genitalia.
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tropic hypogonadism such as Kallmann syndrome.
Cultural differences in dealing with intersexuality and
other types of abnormal genitalia do not only influence
the patient's own psychosexual development but may also
affect medical decisions regarding sex assignment and
consecutive management [15]. In this case it was difficult
for the patient's physician to give her any information
from the medical evaluation, other than that she is an
infertile female. An unqualified birth attendance may mis-
diagnose the sex of a child with abnormal genital develop-
ment. In the present case, the sex of rearing appeared to be
correct, as the patient regarded herself as female. How-
ever, precise diagnosis and prognosis, including her
potential response to hormonal therapy and subsequent
fertility, remained unclear. The combination of FGM and
the absence of normal female development probably sub-
jected this patient two a twofold psychological trauma.
Considering the international incidence of ambiguous
genitalia cases and the high incidence of FGM in the
Sudan, a significant group of patients with undiagnosed
abnormal genitalia is expected among women subjected
to FGM in this country. Unless religious leaders, govern-
ment, and educationalists work together to clarify these
matters, young individuals will continue to be genitally
mutilated in the Sudan. However in a symposium organ-
ized by the Sudan Ministry of Health in conjunction with
UNICEF, the health minister expressed the Sudanese gov-
ernment's commitment to eradicate the practice of female
circumcision at all levels, and stressed that it is a prohib-
ited act for all medical practitioners. Stiff penalties have
been introduced for those who continue to perform the
operations [8].
Ultra sound showing a mass in the prostate's positionFigure 4
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